HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of intratympanic histamine injection as an adjuvant to dexamethasone in a noise-induced murine model.

Abstract
The safety and efficacy of intratympanic (IT) histamine (HIS) injection as an adjuvant to increase the inner ear penetration of dexamethasone (DEX) was investigated in this study. IT injections of DEX-only, 1% HIS+DEX and 4% HIS+DEX were performed in mice with noise-induced hearing loss. An inflammatory reaction in the middle ear was observed only in the 4% HIS+DEX group although no serious cytotoxic effects on the organ of Corti (OC) were observed at that concentration. Compared with the DEX-only group, the perilymphatic concentration of DEX was approximately two times higher in the 1% HIS+DEX group and approximately five times higher in the 4% HIS+DEX group. The expression of the DEX receptor in the cochlea was significantly increased in the 4%-HIS+DEX group. HIS appeared to induce transient damage the microstructure of the RWM with recovery observed within 3 weeks. The 1 and 4% HIS + DEX groups showed a significant recovery of the OC compared with the control group and they also achieved significantly better hearing restoration at 8 kHz in the DPOAE hearing test (P < .05) when compared to the DEX-only group. IT HIS temporarily disrupts the structure of the RWM and middle ear mucosa and significantly enhances the inner ear penetration of DEX. Therefore, IT HIS injection could be a simple and effective adjuvant therapy to increase perilymph concentration of DEX and achieve OC recovery after cochlear damage.
AuthorsJae Sang Han, Ye Lin Kim, Hyo Jeong Yu, Jung Mee Park, Yeon Ju Kim, Yun-Hoon Choung, So Young Park, Shi Nae Park
JournalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci) Vol. 178 Pg. 106291 (Nov 01 2022) ISSN: 1879-0720 [Electronic] Netherlands
PMID36058499 (Publication Type: Journal Article)
CopyrightCopyright © 2022. Published by Elsevier B.V.
Chemical References
  • Adjuvants, Immunologic
  • Adjuvants, Pharmaceutic
  • Dexamethasone
  • Histamine
Topics
  • Adjuvants, Immunologic
  • Adjuvants, Pharmaceutic
  • Animals
  • Dexamethasone (pharmacology)
  • Disease Models, Animal
  • Histamine
  • Injection, Intratympanic
  • Mice
  • Perilymph

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: